The UK is planning to treat coronavirus patients with blood taken from people who have survived the disease.
The announcing of this medical trial raises an obvious question: if doctors can attempt to treat hospitalized coronavirus patients with an untried approach based on the use of blood products, why can’t they try using vitamin C – an approach which has already been used in China and the United States and shown to work?
In China, a medical team from the Second Affiliated Hospital of Xi’an Jiaotong University recently reported the successful treatment of coronavirus patients with vitamin C. In a press release posted on the hospital website, the team describe how patients suffering from severe coronary pneumonia, a potentially fatal complication of the coronavirus, have recovered after being treated with high doses of the vitamin. The medical team recommend that for critically ill patients and those with severe neonatal pneumonia, vitamin C treatment should be initiated as soon as possible after admission to hospital. Significantly, the Shanghai Medical Association now officially recommends high-dose vitamin C for treatment of the coronavirus.
In the United States, doctors in New York state are similarly treating coronavirus patients with high doses of vitamin C. Speaking to the New York Post newspaper, Dr. Andrew G. Weber, a pulmonologist and critical care specialist on Long Island, said he now immediately gives his intensive care coronavirus patients 1,500 milligrams of intravenous vitamin C. This treatment is then repeated three or four times a day. A spokesman for Northwell Health, which runs 23 hospitals and is the largest healthcare provider in New York state, told the New York Post that vitamin C is now being “widely used” as a coronavirus treatment at its facilities.
The reason why vitamin C and other natural approaches are largely being ignored in the search for treatments for the coronavirus is that, across the world, healthcare is largely dominated by the trillion-dollar a year pharmaceutical investment industry. Safe and effective natural health approaches pose a threat to the future of this industry as they reduce the market for its patented drugs. To learn more about the pharmaceutical investment industry and its trillion-dollar a year ‘business with disease’, read this special feature page on our website.